Improved Quality of Life
Guardian is indicated for use in patients who have had prior acute coronary syndrome (ACS) events, including heart attacks, and who remain at high risk for recurrent events.
Guardian is indicated for use in patients who have had prior acute coronary syndrome (ACS) events, including heart attacks, and who remain at high risk for recurrent events.
These testimonials relate accounts of GUARDIAN recipient responses to the treatment. These patient accounts are genuine, typical, and documented. However, they do not provide any indication, guide, warranty or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patients.
Felt safer and more in control.
Reported improved quality of life.
Experienced less anxiety.
Worried less when exercising.
Felt they were more productive.
Experienced better sleep.
The chances of surviving an ACS event have never been better, thanks in large part to advancements in intervention not only at the hospital, but in the ambulance as well. Still the facts surrounding ACS events are irrefutable.
About 805,000 people will suffer a heart attack this year.1
Another 200,000 will have a recurrent coronary event.1
It is estimated that 45% of these events will be “silent” heart attack with few, if any recognized symptoms.2
A heart attack, also called a myocardial infarction, can be fatal. One
person dies every 34 seconds in the United States from cardiovascular
disease.1
While advances in cardiac interventions and therapies have improved
patient outcomes, reliably getting patients to the hospital in a
timely manner presents one of the greatest challenges today. This is
critical to improving patient outcomes.
*A portion of the ALERTS subjects were evaluated in a sub-study that examined quality of life. The results showed that many patients reported having less stress, improvements in sleep, less anxiety during exercise, and improvements in other areas.